Mode of Actions of Bile Acids in Avoidance of Colorectal Cancer Development; and their Therapeutic Applications in Cancers - A Narrative Review


Bile Acids
programmed cell death
synthetic Bile Acids

How to Cite

Kaur, K. K. ., K. Allahbadia, G. N. ., & Singh, M. . (2022). Mode of Actions of Bile Acids in Avoidance of Colorectal Cancer Development; and their Therapeutic Applications in Cancers - A Narrative Review. Journal of Pharmacy and Nutrition Sciences, 12, 35–53.


Bile Acids (BAs) possess a considerably significant part in the form of emulsifiers in digestion besides absorption of dietary lipids. BAs represent amphiphilic molecules, that are primary metabolites formed from cholesterol by the aid of enzymes acting on cholesterol. Earlier BAs were believed to be tumor repressors. The tumor repressive actions of BAs are correlated with programmed cell death (PCD). Furthermore, dependent on this observation different Synthetic BAs products have been generated along with their utilization regarding induction of PCD (in the form of apoptosis, autophagy or necroptosis in variable kinds of human cancers. Thus we conducted a narrative review till August 2022. The present article might form the basis of generationof such innovative therapies even for cancers/tumors that are cisplatin resistant. With time these therapies might be used for the treatment of neurodegenerative diseases (NDD), amyotrophic sclerosis, and numerous metabolic and haematological diseases as described for use of TUDCA.


Wei S, Ma X, Zhao Y. Mechanism of hydrophobic Bile Acids-induced hepatic injury and drug discovery. Front Pharmacol 2016; 11: 1084.

Kundu S, Kumar S, Bajaj A. Crosstalk between Bile Acids and progression and development ofCancer and its therapeutic implications. IUBMB Life 2015; 67: 514-23.

Martinez-JD, Stratagoules ED, LaRue JM, Powell AA, Gause PR, Craven MT, et al. Different Bile Acids exhibit distinct biological effects. The tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr Cancer 1998; 31: 111-18.

Jang JY, Im EO, Choi YH, Kim ND. M of Bile Acids induced Programmed Cell Death and drug discovery against cancer. Int J Mol Sci 2022; 23: 7184.

Martinot E, Sedes L, Baptissart M, Lobaccaro JM, Caira F, Beaudoin C, et al. Bile Acids and its receptor. Mol Asp Med 2017; 56: 2-9.

Blanchet M, Brunel JM. Bile Acid derivatives: from old molecules to a new potent therapeutic use: an overview. Curr Med Chem 2018; 25: 3612-36.

DiCiaula A, Garruti G, Lunardi Bacetto R, Molina Molina E, Bonfrate L, Wang DQ, et al. Bile Acid physiology. Ann Hepatol 2017; 16: s4-s14.

Danic M, Stanimirov B, Pavlovic N, Golocorbin-Kon S, AlSalami H, Stankov K, et al. Pharmacologic applications of Bile Acids and their derivatives in the treatment of Metabolic Syndrome. Front Pharmacol 2018; 9: 1084.

Cook J, Kennaway E, Kennaway N. Production of tumors by deoxycholic acid. Nature 1940; 145: 627.

Sharma R, Quilty F, Gilmer JF, Long A, Byrne AM. Unconjugated secondary Bile Acids activate unfolded protein response induce golgi fragmentation via a Src dependent mechanism. Oncotarget 2017; 8: 967-78.

Liu H, Xu HW, Zhang YZ, Huang Y, Han GQ, Liang TJ, et al. Ursodeoxycholic acid induces apoptosis in Hepatocellular carcinoma in mice. World J Gastroenterol 2015; 21: 10367-74.

Wu YC, Chiu CF, Hseuh CT, Hseuh CT. The role of bile acid in cellular invasiveness of gastric cancer. Cancer Cell Int 2018; 18: 75.

Phelan JP, Reen FJ, Camparos Martin JA, O'Comnnor R, O'Gara F. Rethinking the bile acid/ gut microbiome axis in cancer. Oncotarget 2017; 8: 115736-47.

Park SE, Choi HJ, Yee SB, Chung HY, Suh H, Choi YH, et al. Synthetic bile acid derivatives inhibit cell proliferation and induce apoptosis in HT-29 human cancer cells. Int J Oncol 2004; 25: 231-6.

Katona BW, Anant S, Covey DF, Stenson WF. Characteristization of enantiomeric bile acid induced apoptosis in colon cancer cell lines. JBiol Chem 2009; 284: 3354-64.

Agarwal DS, Mazumdar S, Italiya KS, Chitkara D, Sakhuja R. Bile acid appended triazoyl aryl ketones: design, synthesis, in vitro anti cancer pharmacokinetics in rats. Molecules 2021; 26: 5741.

Melloni E, Marchesi E, Preti L, Casciano F, Rimondi E, Romani A, et al. Synthesis and biologicalnvestigations of bile acid-paclitaxel hybrids. Molecules 2022; 27: 471.

Brossard D, ElKilheil L, Clement M, Sebbahi W, Khalid M, Roussakis C, et al. Synthesis of bile acid derivatives and in vitro cytotoxic activity with proapoptotic process on KMS-11multiple myeloma (KMS-11), glioblastoma multiform (GBM) and coloniccarcinoma (HCT-116) human cell lines. Eur J Med Chem 2010; 45: 2912-18.

Singh M, Singh A, Kundu S, Bansal S, Bajaj A. Deciphering the role of charge, hydrophobicity for cytotoxic activitities and interaction of bile acid based facial ampiphiles. Biochim Biophys Acta 2013; 1828: 1926-37.

El Kihel L, Clement M, Bazin MA, Descamps G, Khalid M, Rault S. New lithocholic acid and chenodeoxycholic acid piperazine carboxamides with anti proliferative and proapoptoticeffects on cancer cell lines. Bioorg Med Chem 2008; 16: 8737-44.

Singh M, Bansal S, Kundu S, Bhargava P, Singh A, Motiani RK, et al. A synthesis structure activity relationship and mechanistic investigation of lithocholic acid amphiphiles for colon cancer therapy. Medchemcomm 2015; 6: 192-201.

Sreekanth V, Bansal S, Motiani RK, Kundu S, Muppu SK, Majumdar TD, et al. Design, synthesis and mechanistic investigations of bile acid-tamoxifen conjugates for breast cancer therapy. Bioconj Chem 2013; 24: 1468-84.

Tang Y, Blomenkamp KS, Fickert P, Trauner M, Teckman JH. Nor UDCA promotes degradation of α1 antitrypsin by inducing autophagy through AMPK/ULK1 pathway. PLoSONE 2018; 13: e0200897.

Markov AV, Babich VO, Popaduek II, Solamatina OV, Logashenko EB, Salakhutdinov NF, et al. Novel derivatives of deoxycholic acid bearing linear aliphatic diamine andaminoalcohol moieties and their cyclic analogs at the 3 position: synthesis and evaluation of their in vitro anti tumor potential. Molecules 2019; 24: 2644.

Yan G, Elbadawy M, Efferth T. Multiple Cell death modalities and their key features. World Acad Sci J 2020; 2: 39-48.

Galluzzi L, Vitale I, Aaronson SI, Abrams JA, Adams D, Agostinis P, et al. Molecular mechanisms of Cell Death: Recommendations of the Nomenclature Committee on Cell death 2018. Cancer Cell Differ 2018; 25: 486-54.

Nguyen TT, U TT, Kim NH, J YD. Role of bile acids in colon carcinogenesis. World J Clin Cases 2018; 6: 577-88.

Payne CM, Bernstein C, Dvorak K, Bernstein H. Hydrophobic bile acids, Genome instability, Darwinian selection and colon carcinogenesis. Clin Exp Gastroenterol 2008; 1: 19-47.

Wu J, Gong J, Geng J, Song Y. Deoxycholic acid induces the overexpression of mucin, MUC2 via NFκB signaling pathway in human esophageal adenocarcinoma cells. BMC Cancer 2008; 8: 333.

Tucker ON, Dannenbeeg AJ, Yang EK, Fahey TJ 3rd. Bile Acids induce cyclooxygenase2 expression in human pancreatic cancer cell lines. Carcinogenesis 2004; 25: 419-23.

Barrasa JI, Olmo N, Lizarbe MA, Turnay J. Bile Acids in the colon, from healthy tocytotoxic molecules. Toxicol Vitr 2013; 27: 964-77.

Sun J, Kato I. gut microbiota, inflammation and colorectal cancer. Genes Dis 2016; 3: 130 -43.

Zimber A, Chedeville A, Abita JP, Barbu V, Gespach C. Functional interactions between bile acids, all-trans-retinoic acid, 1, 25 dihydroxy VitaminD3 on monocyte differentiation andmyeloblastic gene downregulation in HL60 and THP1 human leukaemia cells. Cancer Res 2000; 60: 672-8.

Wu Z, Lu Y, Wang B, Liu C, Wang ZR. Effects of bile acids on proliferation and ultra structural alterations of pancreatic cancer cell lines. World J Gastroenterol 2003; 9: 2759-63.

Pyo JS, Ko YS, Kang G, Kim DH, Kim WH, Lee BL, et al. Bile Acid induces MUC2 expression and inhibitstumor invasionin gastriccarcinoma. J Cancer Res Clin Oncol 2015; 141: 1181-8.

Yu H, Fu QR, Huang ZJ, Lin JY, Chen QX, Wang Q, Shen DY. Apoptosis induced by urso deoxycholic acid in human melanoma cellsthroughthe mitochondrial pathway. Oncol Rep 2019; 41: 213-23.

Vandewynckel YP, Laukens D, Devisscher L, Peridaens A, Bogaerts E, Verhelst X, et al. Taurourso deoxycholic acid dampensOncogenic apoptosis induced by endoplasmic reticulum (ER) stress during hepatocarcinogen exposure. Oncotarget 2015; 6: 28011-25.

Kim YH, Kim JH, Kim BG, Lee KL, Kim JW, Koh SJ. Tauroursodeoxycholic acid attenuates colitis induced colon cancer by inhibiting nuclear factor κB signaling. J Gastroenterol Hepatol 2019; 34: 544-51.

Phelan JP, Reen FJ, Dumphy N, O'Comnnor R, O'Gara. Bile Acids destabilize HIF-alpha andpromote antitumor phenotypes in cancer cell models. BMC Cancer 2016; 16: 476.

Debruyne PR, Bruyneel EA, LiX, Zimber A, Gespach C, Mareel MM. The role of bile acids in carcinogenesis. Mutat Res 2001; 480-481: 359-69.

Alberts DS, Martinez ME, Hass LM, Einspahr JG, Green SB, Bhattacharyya AK, et al. Phase III trials of ursodeoxycholic acid to prevent colorectal adenoma recurrence. J Natl Cancer Inst 2005; 97: 3846-53.

Tung BY Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primar bile acid y sclerosing cholangitis, Ann Intern Med 2001; 134: 89-95.

Serfaty L, DeLeusse A, Rosmurduc O, Desaint B, Flejou JF, Chazouilleres O, et al. Ursodeoxycholic acid and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study. Hepatology 2003; 38: 203-9.

Huang WK, Hsu HC, Liu JR, Yang TS, Chen JS, Chang JW, et al. The association of ursodeoxycholic acid use with colorectal cancer risk: a national cohort study. Medicine 2016; 95: e2980.

Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide ranging tissue kinetics. Br J Cancer 1972; 26: 239-57.

D'Arcy MS. Cell Death: A review of the major forms of apoptosis, necroptosis and autophagy. Cell Biol Int 2019; 43: 582-92.

Zhao J, Hu Y, Peng J. Targeting programmed cell death in Metabolic dysfunction associated fatty liver disease (MAFLD): a promising new therapy. Cell Mol Biol Lett 2021; 26: 17.

Su Z, Yang Z, Xu Y, Chen Y, Yu Q. Apoptosis, autophagy, necroptosis and Cancer metastasis. Mol Cancer 2015; 14: 48.

Erekat NS. Apoptosis and its therapeutic implications inneurodegenerative diseases. Clin Anat 2022; 35: 65-78.

Obeng E. Apoptosis (programmed cell death) and its signals. -a review. Braz J Biol 2021; 81: 1133-43.

Mishra AP, Salehi B, Sharifi Rad M, Pezzani R, Kobarfard F, Sharifi Rad J, et al. Programmed cell death: a cancer-perspective: an overview. Mol DiagnTher 2018; 22: 281-95.

Bertheloot D, Latz E, Franklin BS. Necroptosis, pyroptosis and apoptosis: an intricate game of Cell Death. Cell Oncol Mol Immunol 2021; 18; 1106-21.

Fu J, Yu M, Xu W, Yu S. Research progress of bile acids in Cancer. Front Oncol 2021; 11: 778258.

Perez M, Briz O. Bile Acids induced cell injury and protection. World J Gastroenterol 2009; 15: 1677-89.

Chiang JYL. Bile Acids: Regulation of synthesis. J Lipid Res 2009: 50: 1955-66.

Chiang JYL. Recent advances in understanding bile acid homeostasis. F1000 Research 2017; 6: 2029.

Ignacio Barrasa J, Olmo N, Perez Ramos P, Santiago-Gomez A, Lecona E, Turnay J, et al. deoxy cholic acid and chenodeoxcholic acid bile acids induce apoptosis via Oxidative stress in human colon adenocarcinoma cells. Apoptosis 2011; 16: 1054-67.

Shen D, Zeng Y, Zhang W, Li Y, Zhu J, Liu Z et al. Chenodeoxycholic acid inhibits lung adenocarcinoma progression via integrin α-5 β 1 / FAK/ p53 signaling pathway. Eur J Pharmacol 2022; 923: 174925.

Izaka T, Tsuji M, Oyamada H, Morio Y, Oguchi K. Interaction between caspase activation and endoplasmic reticulum (ER) stress in glycochenodeoxcholic acid inducedapoptotic Hep G2 cells. Toxicology 2007; 241: 146- 56.

Yang HB, Song W, Cheng MD, Fan HF, Gu X, Qiao Y, et al. Deoxcholic acid inhibits BGC-823 gastric carcinoma cells via a p53 mediated pathway. Mol Med Rep 2015; 11: 2749-54.

Yui S, Kanamoto R, Saeki T. Deoxcholic acid can induce apoptosis in the human colon cancer cell lines HCT 116 in the absence of Bax. Nutr Cancer 2008; 60: 111-18.

Luu TH, Bard JM, Carbonelle D, Chaillou C, Huvelin JM, Bobin Dubigeon C, et al. Lithocholic bile acid inhibits lipogenesis and induces apoptosisin breast cancer cells. Cell Oncol 2018; 41: 13-24.

Goldberg AA, Titorenko VI, Beach A, Sanderson JT. Bile Acids induce apoptosis selectively in androgen dependent and independent PC3prostate cancer cells. Peer J 2013; 1: e122.

Trah J, Arand J, Oh J, Pagerols Raluy L, Trochimiuk M, Appl B, et al. Lithocholic bile acid induces apoptosis in human neuroblastoma cells: a nonselective treatment option. Sci Rep 2020; 10: 20349.

Yao Z, Zhang X, Zhao F, Wang S, Chen A, Hang B, et al. Ursodeoxycholic acidi inhibits glioblastoma progression via endoplasmic reticulum stress bile acid related apoptosis and synergises with thecyst proteasome hampering agent bortezomib. ACS Chem 2020; 11: 1337-46.

Lee WS, Jung JH, Panchanathan R, Yun JW, Kim DH, Kim HJ, et al. Ursodeoxycholic acid induces death receptormediated apoptosis in prostate cancer cells. J Cancer Prev 2017; 22: 16- 21.

Lim SC, Duong HQ, Parajuli KR, Han SI. Proapoptotic role of the MEK/ERK pathwayin Ursodeoxycholic acid induced apoptosis in SNU 601 gastric cancer cells. Oncol Rep 2012; 28: 1429-34.

Lim SC, Duong HQ, Choi JE, Lee TB, Kang JH, Oh SH, Han SI. Lipid raft dependent death receptor 5(DR5) expression and activation are critical for Ursodeoxycholic acid induced apoptosis in gastric cancer cells. Carcinogenesis 2011; 32: 723-31.

Jung HW, Hwang JH. Anti cancer effects of Ursodeoxycholic acid in FRO anaplastic thyroid cancer cells. Molecules 2022; 26: 5309.

Jang JY, Sung B, Kim ND. Role of induced Programmed cell death in the chemopreventive potential of apigenin. Int J Mol Sci 2022: 23: 3757. 22: 7808.

Su T, Li X, Yang ZM, Shao Q, Zhao Y, Ma C, Wang P. Autophagy: an intracellular degradation pathway regulating plant survival and stress response. Front Plant Sci 2020; 11: 64.

Li X, H S, Ma B. Autophagy and autophagy related proteins in cancer. Mol Cancer 2020; 19: 12.

Ravanan P, Srikumar IF, Talwar P. Autophagy: The spotlight for cellular stress response. Life Sci 2018; 188: 53-67.

Zada S, Hwang JS, Ahmed M, Lai TH, Pham TM, Elashkar O, Kim DR. Crosstalk between autophagy and Oncogenic signaling pathway andimplications for cancertherapy. Biochim Biophys Acta Rev Cancer 2021; 1876: 188565.

Yang Q, Wang R, Zhu L. Chaperone-mediated autophagy. Adv Exp Med Biol 2018; 1206: 435-52.

Menon MB, Dhamija S. Beclin1 phosphorylation-at the center of autophagy regulation. Front Cell Dev Biol 2018; 6: 137.

Wijshake T, Zou Z, Chen B, Zhong L, Xiao G, Xie Y, et al. Tumor suppressor function of Beclin1 in breast cancer cells requires E-cadherin. Proc Natl Acad Sci USA 2021; 118.

Roesly HB, Khan MR, Chen HD, Hill KA, Narendran N, Watts GS, et al. The decreased expression of Beclin1 correlates with progression to esophageal adenocarcinoma: the role of deoxycholic acid. Am J Physiol Gastroenterol Liver Physiol 2012; 302: G864- G872.

Gafar AA, Draz HM, Goldberg AA, Bashandy MA, Bakry S, Khalifa MA, et al. lithocholic acid induces endoplasmic reticulum stress, mitochondrial dysfunction in human prostate cancer cells. Peer J 2016; 4: e2445.

Lim SC, Han SI. Ursodeoxycholic acid effectively kills drug resistant gastric cancer cells through induction of autophagic death. Oncol Rep 2015; 34: 1261-8.

Zanetti LC, Weinlich R. Necroptosis, the other main caspase independent Cell Death. Adv Exp Med Biol 2021; 1301: 123-38.

Choi ME, Price DR, Ryter SW, Choi AMK. Necroptosis: Acrucial pathogenic mediator of human disease. JCI Insight 2019; 4: e128834.

Weinrich R, Oberst A, Beere HM, Green DR. Necroptosis in development, inflammation and disease. Nat Rev Mol Cell Biol 2017; 18: 127-36.

Chen J, Kos R, Garssen J, Redegeld F. Molecular Insights into the mechanism of Necroptosis: the necrosome as a potential therapeutic target. Cells 2019; 8: 1486.

Seifert L, Miller G. Molecular pathways: the necrosome - a target for cancer therapy. Clin Cancer Res 2017; 23: 1132-6.

Cai Z, Jitkaew S, Zhao J, Chiang HC, Choksi S, Liu J, et al. Plasma membrane translocation of trimerized of MLKL is for TNF induced necroptosis. Nat Cell Biol 2014; 16: 55-65.

Maelfait J, Liverpool L, Bridgeman A, Ragan KB, Upton JW, Rehwinkei J. Sensing of viral and endogenous RNA by ZBD1/ DAI induced necroptosis. EMBO J 2017; 36: 2529-43.

Riegler AN, Brissac T, Gonzalez Juarbe N, Orihuela CJ. Necroptic Cell Death promotes adaptive immunity against colonizing pneumococci. Front Immunol 2019; 10: 615.

Galluzzi L, Kepp O, Chan FK, Kroemer G. Necroptosis: mechanisms and relevance in disease. Annu Rev Pathol 2017; 12: 103-30.

Seifert L, Werba G, Tiwari S, Giao Ly NN, Alothman S, Alqunaibit D, et al. The necrosome promotes pancreatic oncogenesis viaCXCL1 andMincle induced immune suppression. Nature 2016; 532: 245-9.

Fulda S. targeting apoptosis for anticancer therapy. Semin Cancer Biol 2015; 31: 84-8.

Qin X, Ma D, Tan YX, Wang HY, Cai Z. The role of necroptosis in cancer: a double edged sword? Biochim Biophys Acta Rev Cancer 2019; 1871: 259-66.

Wada N, Kawano Y, Fujiwara S, Kikukawa Y, Okuno Y, Tasaki M, et al. Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells. Int J Oncol Rep 2015 46; 963-72.

Xu Y, Ma HB, Fang YL, Zhang ZR, Shao J, et al. Cisplatin- induced necroptosis in TNF-α dependent and independent pathway S. Cell Signal 2017; 31: 112-23.

Hannes S, Abhari BA, Fulda S. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked. Cancer Lett 2016; 380: 31-8.

Cekay M, Roesler S, Frank T, Knuth AK, Eckhart I, Fulda S. Smac mimetics and type II interferon-synergistically induce necroptosis in various cancer cell lines. Cancer Lett 2017; 410: 228-37.

Weber K, Roelandt R, Bruggeman I, Estornes Y, Vanden-abeele P. Nuclear RIPK3 and MLKL contribute to cytosolic necrosome formation and necroptosis. Commun Biol 2018; 1: 6.

Dhuria YK, Sharma D. Necroptosis: A regulated mode of Cell Death. J Neuroinflamm 2018; 15: 199.

Meng H, Liu Z, Li X, WangH, J T, W G, et al. Death domain dimerization mediated activation RIPK1 controls necroptosis and RIPK1 dependent apoptosis. Proc Natl Acad Sci USA 2018; 115: E2001-9.

Chen X, He WT, Hu L, Li J, Fang Y, Wang X, et al. Pyroroptosis is driven by non selective gasdermin D pore and its morphology is different from MLKL channel mediated necroptosis. Cell Res 2016; 26: 1007-20.

Hoff J, Xiong L, Kamman T, Neugebauer S, Michael JM, Ghail M, et al. RIPK 3 promoter hyper methylation in hepatocytesprotects from bile acid induced inflammation and necroptosis. bioRxiv 2021.

Cao M, Chen F, Xie N, Cao MY, Chen P, Lou Q, et al. c-Jun-N-terminal kinases differentially regulate TNF and TLRs mediated necroptosis through their kinase dependent and independent activities. Cell Death Dis 2018; 9: 1140.

Alfonso MB, Rodriques PM, Simao AL, Ofengeim D, Carvalho T, Amaral JD, et al. Activation of necroptosis in human and experimental cholestasis. Cell Death Dis 2016; 7: e2390.

Yang H, Duan J. Bile Acids and the potential role of primary biliary cirrhosis. Digestion 2016; 94: 145-53.

Lan W, Chen Z, Chen Y, Tan M, Chen Y, et al. Glycochenodeoxcholic acid impairs transcriptionfactor E- dependent autophagy- lysosome machineryby disrupting Reactive oxygen species homeostasis in L02 cells. Toxicol Lett 2020; 331: 11-21.

Van de Wiel SMW, Porteiro B, Belt SC, Vogels EMW, Bolt I, Vermuelen JLM, et al. Differential and organ specific functions of organic solute transporter α and β in experimental cholestasis. JHEP Rep 2022; 4: 100463.

Zhou X, Xie L, Bergmann F, Endris V, Strobel O, Buchler MW, et al. The bile acid receptor FXR attenuates pancreatic acinar cell autophagy- induced in chronic pancreatitis. Cell Death Discov 2017; 3: 17027.

Muili KA, Wang D, Orabi AI, Sarwar S, Luo Y, Javed TA, et al. Bile acids induce pancreatic acinar cell injury and pancreatitis by activating calcineurin. J Biol Chem 2013; 288: 570-80.

Choi YH, Im EO, Suh H, Jin Y, Lee WH, Yoo YH, et al. Apoptotic activity of novel Bile acid derivatives in human leukaemic cells through the activation of caspases. Int J Oncol 2001; 18: 979-84.

Im EO, Choi SH, Suh H, Choi YH, Yoo YH, Kim ND. Synthetic novel Bile acid derivatives induce apoptosis through a c-Jun-N-terminal kinase and NFκappa B dependent process in human cervical carcinoma cells. Cancer Lett 2005; 229: 49- 57.

Im EO, Choi YH, Paik KJ, Suh H, Jin Y, Kim KW, et al. novel Bile acid derivatives induce apoptosis via a p53-independent pathway in human breast carcinoma cells. Cancer Lett 2001; 163: 83-93.

Choi YH, Im EO, Suh H, Jin Y, Yoo YH, Kim ND. Apoptosis and modulation of Cell cycle control by Synthetic derivatives of ursodeoxcholic acid and chenodeoxcholic acid in human prostate cancer cells. Cancer Lett 2003; 199: 157-67.

Moon B, Kim MC, Park JS. Synthetic CDCA derivatives induced apoptosis of stomach cancerSNU1 cells. Cancer Res Treat 2004; 36: 132-9.

Yee SB, Yeo WJ, Park BS, Kim JY, Baek SJ, Kim YC, et al. Synthetic chenodeoxcholic acid derivatives inhibit glioblastoma multiform tumor growth in vitro and in vivo. Int J Oncol 2005; 27: 653-9.

Park SE, Lee SW, Hossain MA, Kim MY, Kim MN, Ahn EY, et al. A chenodeoxcholic acid derivative, HS1200 induces apoptosis and cell cycle modulation via Egr 1gene expres-sioncontrol on hepatoma cells. Cancer Lett 2008; 270: 77-86.

Kim TH, Yoo YH, K DY, Suh H, Park MK, Park KH, et al. Efficacy on anaplastic thyroid carcinoma of valproic acid alone or in combination with doxorubicin, a Synthetic chenodeoxcholic acid derivativeor lactacystin. Int J Oncol 2009; 34: 1353-62

Kim ND, Im EO, Yoo YH, Choi YH. Modulation of the cell cycle and induction of apoptosis in human cancer cells by sy-nthetic bile acids. Curr Cancer DrugTargets 2006; 6: 681-9.

Aubrey BJ, Kelly JL, Janic A, Herold MJ, Strasser A. Howdoes p53 induce apoptosis and howdoes this relate top53 mediated tumor suppression. Cell Death Differ 2018; 25: 104-13.

Unnisa A, Greig NH, Kamal MA. Iinhibition of caspase-3 and caspase-9 mediated apoptosis: a multimodal therapeutic target in traumatic brain injury. Curr Neuropharmacol 2022; 20: 121898.

Lopez J, Tait SW. Mitochondrial apoptosis: Killing enemy using the enemy within. Br J Cancer 2015; 112: 957-62.

Boice A, Bouchier -Hayes L. Targeting apoptotic caspases in cancer. Biochim Biophys Acta Mol Cell Res 2020; 1867: 118688.

Zaman S, Choi Wang R, Gandhi V. Targeting the apoptosis pathway in haematological malignancies. Leuk Lymphoma 2014; 55: 1980-92.

Zhao DY, Jacobs KM, Hallahan DE, Thotala D. Silencing radiation induced apoptosis in normal tissues while killing cancer cells and delaying tumor growth. Mol Cancer Ther 2015; 14: 2343 -52.

Gitenay D, Baton VT. Is EGR1 a potential target for prostatic cancer therapy? Future Oncol 2009; 5: 9931003.

Oh S, Kim H, Nam K, Shin I. Egr 1 is required for neu /HER 2 induced mammary tumors. Cell Signal 2018; 45: 102-9.

Lee SM, Park MS, Park SY, Choi YD, Chung JO, Kim DH, et al. Primary bile acid activates Egr 1 expression through the MAPK signaling pathwayin gastric cancer. Mol Med Rep 2022; 25: 129.

Kim ND, Moon JO, Slitt AL, Copple BL. Early growth response factor 1 is critical for cholestatic liver injury. Toxicol Sci 2006; 90: 586-95.

Sui X, Kong N, Ye L, Han W, Zhou J, Zhang Q, et al. p38 and JNK MAPK pathways the balance of apoptosis and autophagyin response to chemotherapeuticagents. Cancer Lett 2014; 344: 174-9.

Czaja MJ. The future of GI and. liver research: editorial perspectives III: JNK/ AP1 regulation of hepatocyte death. Am J Physiol Gastroenterol Liver Physiol 2003; 284: G875- G879.

Glinghammar B, Holmberg K, Rafter J. Effects of colonic luminal components on AP1 dependent gene transcription in cultured human colon carcinoma cells. Carcinogenesis 1999; 20: 969-76.

Brady LM, Beno DW, Davis BH. Bile acid induced stimulation of Early growth response gene and mitogen activated protein kinase is protein kinase C dependent. Biochem J 1996; 316Pt3: 765-9.

Qiao D, Chen W, Stratagoules ED, Martinez JD. Bile acid induced activation of activator protein requires both extracellular signal -regulated kinase and protein kinase C signaling. J Biol Chem 2000; 275: 15090-98.

HiguchiH, Grambihler A, Canbay A, Bronk SF, Gores GJ. Bile acids upregulate death receptor5/TRAIL receptor2 expressionvia a c-Jun-N-terminal kinaseinvolving Sp1. JBiol Chem 2004; 279: 51-60.

Yin SL, Yu X. Arsenic induced apoptosis in the p53 proficient and p53deficient cells through modulationof NFκBpathway. Food Chem Toxicol 2018; 118: 849-60.

Abu Rmilah A, Fauci R, WattK, Krowka M, Wiesner R, Murray D, et al. Association of α1 antitrypsin phenotype and developmentof advanced liver disease and pulmonary complications before and after liver Transplantation. Transplantation 2021; 105: 1576-84.

Caliceti C, Punzo A, Silla A, Simoni P, Roda G, HrelIa S. New insights into Bile acids related signaling in the onset of colorectal cancer. Nutrients 2022; 14: 2964.

Kaur KK, Allahbadia GN, Singh M. Have Probiotics and Synbiotics passed the test of time to be implemented in management of obesity and related metabolic disorders-a comprehensive review. Adv Obes Weight Manag Control 2019; 9(1): 21-28.

Kaur KK, Allahbadia GN, Singh M. Will Probiotics Provide the Answer for Therapy of Non-alcoholic Fatty Liver Disease (NAFLD)? - A Systematic Review. Biochem Physiol 2020; 9: 257.

Kaur KK. Delivered a talk on 30th September on 'Advantages and Limitations of utilizing Clostridium species as Probiotics-ASytematic Review'' in a webinar held by Gastroenterology conference on 30th September 2021.

Kaur KK, Allahbadia GN, Singh M. Utilization of Clostridium Species as Probiotics as an Alternative to the Conventional Probiotics like Lactobacillus rhamnosus /Bifidobacterium-How Far is it Feasible-A Systematic Review. J Endocrinol-2021; 5(1): 1-12.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.